Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7676
National Healthcare
NHC
$3.5B
| $311K | ﹤0.01% |
4,908
-3,341
| -41% | -$224K |
|
|
FLNA
7677
PUT
Filana Therapeutics
FLNA
$44.1M
| $311K | ﹤0.01% |
+101,100
| New | +$459K |
|
|
TMHC
7678
CALL
DELISTED
Taylor Morrison
TMHC
| $311K | ﹤0.01% |
16,100
-19,100
| -54% | -$301K |
|
7679
PUT
ProShares Ultra Gold
UGL
$801M
| $311K | ﹤0.01% |
19,200
-52,800
| -73% | -$800K |
|
7680
Dorchester Minerals
DMLP
$1.36B
| $310K | ﹤0.01% |
24,225
-838
| -3% | -$9.53K |
|
7681
Exponent
EXPO
$3.19B
| $310K | ﹤0.01% |
3,826
-181,888
| -98% | -$13.1M |
|
7682
CALL
VirnetX Holding Corp
VHC
$62.8M
| $310K | ﹤0.01% |
2,385
-580
| -20% | -$71K |
|
7683
PUT
Atmos Energy
ATO
$28.7B
| $309K | ﹤0.01% |
3,100
-3,700
| -54% | -$373K |
|
7684
iShares MSCI Brazil Small-Cap ETF
EWZS
$205M
| $309K | ﹤0.01% |
24,497
-147,402
| -86% | -$1.63M |
|
7685
Health Catalyst
HCAT
$139M
| $309K | ﹤0.01% |
10,587
+1,764
| +20% | +$48.7K |
|
|
OPRA
7686
Opera Ltd
OPRA
$1.82B
| $309K | ﹤0.01% |
34,378
-61,893
| -64% | -$386K |
|
|
STR
7687
DELISTED
Sitio Royalties
STR
| $309K | ﹤0.01% |
24,115
+8,240
| +52% | +$86.5K |
|
7688
Atlassian
TEAM
$41.2B
| $309K | ﹤0.01% |
1,713
-816,390
| -100% | -$136M |
|
7689
PUT
Adtran
ADTN
$684M
| $308K | ﹤0.01% |
28,200
+6,100
| +28% | +$63K |
|
7690
Banc of California
BANC
$3.13B
| $308K | ﹤0.01% |
28,404
-74,657
| -72% | -$750K |
|
|
IQIN
7691
DELISTED
NYLI 500 International ETF
IQIN
| $308K | ﹤0.01% |
13,010
-50,856
| -80% | -$1.15M |
|
7692
CALL
Cinemark Holdings
CNK
$4.33B
| $307K | ﹤0.01% |
26,600
-6,700
| -20% | -$90.9K |
|
7693
PUT
Vitamin Cottage Natural Grocers
NGVC
$648M
| $307K | ﹤0.01% |
20,600
-15,200
| -42% | -$185K |
|
7694
CALL
Outfront Media
OUT
$5.33B
| $307K | ﹤0.01% |
22,047
-101
| -0.5% | -$1.42K |
|
7695
Rimini Street
RMNI
$466M
| $307K | ﹤0.01% |
59,559
+42,465
| +248% | +$181K |
|
|
PENG
7696
PUT
Penguin Solutions Inc
PENG
$3.27B
| $307K | ﹤0.01% |
+22,600
| New | +$288K |
|
|
MXDU
7697
DELISTED
Nationwide Maximum Diversification U.S. Core Equity ETF
MXDU
| $307K | ﹤0.01% |
10,011
| – | – |
|
|
CEMI
7698
PUT
DELISTED
Chembio diagnostics, Inc.
CEMI
| $307K | ﹤0.01% |
+94,400
| New | +$896K |
|
7699
CALL
Otter Tail
OTTR
$3.9B
| $306K | ﹤0.01% |
+7,900
| New | +$332K |
|
7700
QCR Holdings
QCRH
$1.74B
| $306K | ﹤0.01% |
9,833
-25,692
| -72% | -$740K |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.